BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34465889)

  • 21. Karyopherin Subunit Alpha 1 Enhances the Malignant Behaviors of Colon Cancer Cells via Promoting Nuclear Factor-κB p65 Nuclear Translocation.
    Zhao L; Wu D; Qu Q; Li Z; Yin H
    Dig Dis Sci; 2023 Jul; 68(7):3018-3031. PubMed ID: 37038032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MKRN2 is a novel ubiquitin E3 ligase for the p65 subunit of NF-κB and negatively regulates inflammatory responses.
    Shin C; Ito Y; Ichikawa S; Tokunaga M; Sakata-Sogawa K; Tanaka T
    Sci Rep; 2017 Apr; 7():46097. PubMed ID: 28378844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WSB1/2 target chromatin-bound lysine-methylated RelA for proteasomal degradation and NF-κB termination.
    Zhang J; Yu Y; Zou X; Du Y; Liang Q; Gong M; He Y; Luo J; Wu D; Jiang X; Sinclair M; Tajkhorshid E; Chen HZ; Hou Z; Zheng Y; Chen LF; Yang XD
    Nucleic Acids Res; 2024 May; 52(9):4969-4984. PubMed ID: 38452206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
    Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
    J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E3 Ligase FBXW2 Is a New Therapeutic Target in Obesity and Atherosclerosis.
    Wang C; Xu W; Chao Y; Liang M; Zhang F; Huang K
    Adv Sci (Weinh); 2020 Oct; 7(20):2001800. PubMed ID: 33101872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase.
    Maine GN; Mao X; Komarck CM; Burstein E
    EMBO J; 2007 Jan; 26(2):436-47. PubMed ID: 17183367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of the SAP18/HDAC1 complex by targeting TRIM56 and Nanog is essential for oncogenic viral FLICE-inhibitory protein-induced acetylation of p65/RelA, NF-κB activation, and promotion of cell invasion and angiogenesis.
    Ding X; Xu J; Wang C; Feng Q; Wang Q; Yang Y; Lu H; Wang F; Zhu K; Li W; Yan Q; Gao SJ; Lu C
    Cell Death Differ; 2019 Oct; 26(10):1970-1986. PubMed ID: 30670829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
    Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
    Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraperitoneal administration of a small interfering RNA targeting nuclear factor-kappa B with paclitaxel successfully prolongs the survival of xenograft model mice with peritoneal metastasis of gastric cancer.
    Inoue M; Matsumoto S; Saito H; Tsujitani S; Ikeguchi M
    Int J Cancer; 2008 Dec; 123(11):2696-701. PubMed ID: 18798274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation.
    Choi KC; Jung MG; Lee YH; Yoon JC; Kwon SH; Kang HB; Kim MJ; Cha JH; Kim YJ; Jun WJ; Lee JM; Yoon HG
    Cancer Res; 2009 Jan; 69(2):583-92. PubMed ID: 19147572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. X-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-{beta}-mediated nuclear factor-{kappa}B activation during breast cancer progression.
    Neil JR; Tian M; Schiemann WP
    J Biol Chem; 2009 Aug; 284(32):21209-17. PubMed ID: 19531477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The p105 NF-ĸB precursor is a pseudo substrate of the ubiquitin ligase FBXO7, and its binding to the ligase stabilizes it and results in stimulated cell proliferation.
    Udasin RG; Gottfried Y; Fabre B; Bercovich B; Ziv T; Ciechanover A
    Biochem Biophys Res Commun; 2021 Jun; 558():224-230. PubMed ID: 32933748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA.
    Ryo A; Suizu F; Yoshida Y; Perrem K; Liou YC; Wulf G; Rottapel R; Yamaoka S; Lu KP
    Mol Cell; 2003 Dec; 12(6):1413-26. PubMed ID: 14690596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hormone-bound vitamin D receptor enhances the FBW7-dependent turnover of NF-κB subunits.
    Fekrmandi F; Wang TT; White JH
    Sci Rep; 2015 Aug; 5():13002. PubMed ID: 26269414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A positive feedback loop of miR-30a-5p-WWP1-NF-κB in the regulation of glioma development.
    Zhao P; Wang M; An J; Sun H; Li T; Li D
    Int J Biochem Cell Biol; 2019 Jul; 112():39-49. PubMed ID: 30978403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GCN5 is a required cofactor for a ubiquitin ligase that targets NF-kappaB/RelA.
    Mao X; Gluck N; Li D; Maine GN; Li H; Zaidi IW; Repaka A; Mayo MW; Burstein E
    Genes Dev; 2009 Apr; 23(7):849-61. PubMed ID: 19339690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A short binding site in the KPC1 ubiquitin ligase mediates processing of NF-κB1 p105 to p50: A potential for a tumor-suppressive PROTAC.
    Goldhirsh G; Kravtsova-Ivantsiv Y; Satish G; Ziv T; Brik A; Ciechanover A
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34873064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Termination of NF-kappaB activity through a gammaherpesvirus protein that assembles an EC5S ubiquitin-ligase.
    Rodrigues L; Filipe J; Seldon MP; Fonseca L; Anrather J; Soares MP; Simas JP
    EMBO J; 2009 May; 28(9):1283-95. PubMed ID: 19322197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients.
    Montagut C; Tusquets I; Ferrer B; Corominas JM; Bellosillo B; Campas C; Suarez M; Fabregat X; Campo E; Gascon P; Serrano S; Fernandez PL; Rovira A; Albanell J
    Endocr Relat Cancer; 2006 Jun; 13(2):607-16. PubMed ID: 16728586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDK5/FBW7-dependent ubiquitination and degradation of EZH2 inhibits pancreatic cancer cell migration and invasion.
    Jin X; Yang C; Fan P; Xiao J; Zhang W; Zhan S; Liu T; Wang D; Wu H
    J Biol Chem; 2017 Apr; 292(15):6269-6280. PubMed ID: 28242758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.